ATP-Binding Cassette Transporter Expression and Methylation Profiles as Potential Biomarkers in Glioma
International Journal of Molecular Sciences · 13.11.2026 · 27 (22) · 10180
DOI: 10.3390/ijms272210180 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.11.2026. Verfasst von Carlos Pilotto Heming und 3 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development (CNPq-Brazil), through the research grant associated with the Research Productivity Fellowship.
Abstract (Originalsprache)
Gliomas are malignant central nervous system tumors characterized by poor prognosis and therapy failure. Adenosine triphosphate-binding cassette (ABC) transporters mediate multidrug resistance via chemotherapeutic efflux, yet their roles as biomarkers across glioma subtypes remain unclear. We analyzed adult diffuse glioma mRNA expression (n = 693; n = 325) and DNA methylation (n = 159) datasets from the Chinese Glioma Genome Atlas in silico, stratifying samples according to the 2021 World Health Organization molecular criteria. ABC transporter profiles, patient-matched methylation–expression correlations (n = 26 overlapping patients; 78 paired gene–sample observations), and prognostic values were evaluated using non-parametric tests with false discovery rate (FDR) correction, Kaplan–Meier curves, and multivariable Cox proportional-hazards regression analyses. Transporter expression and methylation varied significantly by histology and grade. ABCC1 expression increased with malignancy, predicting worse overall survival in univariable analysis (p < 0.0001). Meanwhile, strongly correlated ABCB1 and ABCG2 expressions (Spearman’s ρ = 0.80 in grade 4 tumors) were higher in lower-grade gliomas. Progressive hypomethylation occurred with increasing grade, with significant differential methylation in ABCB1 (FDR p < 0.0001) and ABCG2 (FDR p < 0.0001). In patient-matched integrative analyses, only ABCC1 exhibited a significant inverse association between methylation and expression (Spearman’s ρ = −0.58, p = 0.0019). Baseline clinical multivariable Cox regression (n = 139) suggested that higher ABCB1 and ABCG2 methylation (HR = 0.11, p = 0.03; HR = 0.12, p = 0.04 per 1.0-unit β increase, corresponding to HR = 0.80 and 0.81 per 0.1-unit β increase) may act as protective factors independent of age and grade (though attenuated upon IDH adjustment), whereas higher grade and ABCG2 expression (n = 542; HR = 1.03, p = 0.001) emerged as independent risk factors. Specific ABC transporter profiles could serve as candidate prognostic biomarkers in glioma, warranting external and translational validation.
Förderung
- National Council for Scientific and Technological Development (CNPq-Brazil), through the research grant associated with the Research Productivity Fellowship
Zitieren
APA
Heming, C. P., Meireles, Y., Moura-Neto, V., & Aran, V. (2026). ATP-Binding Cassette Transporter Expression and Methylation Profiles as Potential Biomarkers in Glioma. International Journal of Molecular Sciences, 27(22), 10180. https://doi.org/10.3390/ijms272210180
Vancouver
Heming CP, Meireles Y, Moura-Neto V, Aran V. ATP-Binding Cassette Transporter Expression and Methylation Profiles as Potential Biomarkers in Glioma. International Journal of Molecular Sciences. 2026;27(22):10180. doi:10.3390/ijms272210180
BibTeX
@article{Heming2026,
author = {Heming, Carlos Pilotto and Meireles, Yasminn and Moura-Neto, Vivaldo and Aran, Veronica},
title = {ATP-Binding Cassette Transporter Expression and Methylation Profiles as Potential Biomarkers in Glioma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10180},
doi = {10.3390/ijms272210180}
}
EUVIMED